HemoShear Therapeutics is a company discovering treatments for rare metabolic disorders in children. Its technology helps to recapitulate diseases using tissue from livers of children born with genetic defects, interrogate the disrupted biochemical processes, explore drug intervention strategies, and select drug candidates with high probabilities of clinical success.